BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9239161)

  • 1. [Treatment of acute myelogenous leukemia in patients more than 80 years old].
    Takeyama H; Yamamoto Y; Miyata Y; Yamada H; Watanabe E; Aoki H; Iinuma M
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1089-93. PubMed ID: 9239161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A short duration treatment with intensive consolidation therapy for patients with acute myelogenous leukemia--13 year experience in a single institute].
    Fujiwara M; Satou N; Izumi N; Shibasaki Y; Higashimura M; Tsukada N; Koike T
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1793-8. PubMed ID: 18030012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.
    Kobayashi T; Miyawaki S; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Ohmoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Matsuoka A; Tomonaga M; Ohno R
    J Clin Oncol; 1996 Jan; 14(1):204-13. PubMed ID: 8558199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective analysis of elderly patients > or = 60 years of age with acute leukemia].
    Tabata M; Yoshida M; Izumi T; Kawano C; Kuribara R; Toshima M; Omine K; Takatoku M; Uchida M; Kirito K; Miyazato A; Takahashi H; Hoshino M; Terui Y; Tomizuka H; Otsuki T; Shimizu R; Tsunoda J; Muroi K; Furukawa Y; Amemiya Y; Imagawa S; Komatsu N; Suzuki T; Miura Y
    Rinsho Ketsueki; 1998 Mar; 39(3):176-84. PubMed ID: 9577640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for minimally differentiated acute myeloid leukemia (AML-M0). A report on five cases and review of the literature.
    Yokose N; Ogata K; Ito T; Miyake K; An E; Inokuchi K; Yamada T; Gomi S; Tanabe Y; Ohki I
    Ann Hematol; 1993 Feb; 66(2):67-70. PubMed ID: 8383541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer curable by chemotherapy: acute myelogenous leukemia].
    Ohno R; Tanimoto M; Morishita Y; Morishima Y; Saito H; Yokomaku S; Nagai T; Kodera Y; Minami S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1329-34. PubMed ID: 2730046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length.
    Ohno R; Kato Y; Nagura E; Murase T; Okumura M; Yamada H; Ogura M; Minami S; Suzuki H; Morishima Y
    J Clin Oncol; 1986 Dec; 4(12):1740-7. PubMed ID: 3465875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).
    Ohno R; Kobayashi T; Morishima Y; Hiraoka A; Imai K; Asoh N; Tsubaki K; Tomonaga M; Takahashi I; Kodera K
    Leukemia; 1992; 6 Suppl 2():92-5. PubMed ID: 1578954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia.
    De Witte T; Muus P; De Pauw B; Haanen C
    Cancer; 1990 Sep; 66(5):831-7. PubMed ID: 2386911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complete remission during administration of rhG-CSF in acute myeloblastic leukemia with pneumonia].
    Hayatsu K; Nagai K; Abe A; Murakawa E; Sekiya M
    Rinsho Ketsueki; 1994 Jan; 35(1):59-64. PubMed ID: 7511179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of acute myelogenous leukemia: results of combination chemotherapy with cytarabine, daunorubicin and 6-mercaptopurine.
    Ko WS; Chen LM; Hwang SH; Chao TY; Wang CC; Kao WY; Lee WC; Hwang WS
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Sep; 48(3):185-9. PubMed ID: 1657335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress of chemotherapy in adult acute leukemia].
    Ohno R
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):431-6. PubMed ID: 7887634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of acute nonlymphocytic leukemia with leukemic cell infiltration to the uterus followed by bone marrow relapse].
    Shiga Y; Shichishima T; Aikawa K; Gotoh J; Furukawa T; Yamagiwa A; Ishibashi T; Maruyama Y
    Rinsho Ketsueki; 1994 May; 35(5):501-5. PubMed ID: 8028198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in the treatment of adult acute myeloid leukemia].
    Ohno R
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1053-8. PubMed ID: 9239156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of elderly patients with acute myelogenous leukemia: analysis of 126 AML cases.
    Iwakiri R; Ohta M; Mikoshiba M; Tsutsumi H; Kumakawa T; Mori M
    Int J Hematol; 2002 Jan; 75(1):45-50. PubMed ID: 11843290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia].
    Taguchi H; Kubonishi I; Takehara N; Uemura Y; Iwahara Y; Eguchi T; Miyagi T; Sugito S; Muneishi H; Tanaka Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1309-14. PubMed ID: 1503485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of conventional chemotherapy and short-term intensive chemotherapy in adult acute myeloid leukemia].
    Ohshima T
    Rinsho Ketsueki; 1989 Aug; 30(8):1175-7. PubMed ID: 2601028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute myelogenous leukemia with diabetes insipidus without desmopression administration by anti-leukemic chemotherapy].
    Ino Y; Tsurumi H; Yamada T; Murakami N; Moriwaki H; Muto Y
    Rinsho Ketsueki; 1995 Dec; 36(12):1359-64. PubMed ID: 8587172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard induction and low dose ara-C treatment in patients over 60 with AML or MDS.
    van Geel BM; Huijgens PC; Ossenkoppele GJ; Wijermans PW; Langenhuijsen MM
    Neth J Med; 1989 Oct; 35(3-4):128-36. PubMed ID: 2601790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early establishment of bone marrow hypoplasia by antileukemic chemotherapy with concurrent rhG-CSF in a case of acute myelogenous leukemia complicated with intestinal perforation].
    Ono Y; Ito S; Murai K; Miyairi Y; Enomoto S; Kaneko J; Sugawara T; Numaoka H; Shimosegawa K; Utsugisawa T; Narigasawa Y; Ito T; Ishida Y; Kuriya S
    Rinsho Ketsueki; 1997 Jan; 38(1):41-6. PubMed ID: 9028160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.